Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.7.7.7 (
DNA polymerase
)
17,007
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Human
tetratricopeptide repeat domain 3
(
TTC3
) is a gene on 21q22.2 within the Down syndrome critical region (DSCR). Earlier studies suggest that
TTC3
may be an important regulator in individual development, especially in neural development. As an E3 ligase,
TTC3
binds to phosphorylated Akt and silence its activity via proteasomal cascade. Several groups also reported the involvement of
TTC3
in familial Alzheimer's disease recently. In addition, our previous work shows that
TTC3
also regulates the degradation of
DNA polymerase gamma
and over-expressed TTC3 protein tends to form insoluble aggregates in cells. In this study, we focus on the solubility and intracellular localization of TTC3 protein. Over-expressed
TTC3
tends to form insoluble aggregates over time. The proteasome inhibitor MG132 treatment resulted in more
TTC3
aggregates in a short period of time. We fused the fluorescent protein to either terminus of the TTC3 protein and found that the intracellular localization of fluorescent signals are different between the N-terminal tagged and C-terminal tagged proteins. Western blotting revealed that the TTC3 protein is cleaved into fragments of different sizes at multiple sites. The N-terminal sub-fragments of
TTC3
are prone to from nuclear aggregates and the
TTC3
nuclear import is mediated by signals within the N-terminal 1 to 650 residues. Moreover, over-expressed
TTC3
induced a considerable degree of cytotoxicity, and its N-terminal sub-fragments are more potent inhibitors of cell proliferation than full-length protein. Considering the prevalent proteostasis dysregulation in neurodegenerative diseases, these findings may relate to the pathology of such diseases.
...
PMID:Overexpressed TTC3 Protein Tends to be Cleaved into Fragments and Form Aggregates in the Nucleus. 3020 23